

Is Clomid still on shortage in 2026? Get the latest update on Clomid availability, pricing, and what you can do if your pharmacy is out of stock.
If you've been following the Clomid (Clomiphene Citrate) availability situation over the past few years, you know it's been a rollercoaster. Manufacturer changes, supply chain disruptions, and pharmacy stocking issues have all made it harder for patients to fill their prescriptions on time.
So where do things stand in 2026? Here's what you need to know.
As of early 2026, Clomid is not listed on the FDA Drug Shortage Database. That's the good news. The formal shortage that began around 2019 has been resolved, and both brand-name Clomid and generic Clomiphene Citrate are being manufactured and distributed.
However, "not on shortage" doesn't mean "easy to find everywhere." Many patients still report difficulty finding Clomid at their local pharmacy. Stock levels vary by region, pharmacy chain, and local demand. If your pharmacy tells you they don't have it, that doesn't mean it's unavailable — it may just mean that specific location doesn't stock it regularly.
Here's how we got here:
Even though the national shortage has ended, several factors continue to affect your ability to fill a prescription:
Large chain pharmacies like CVS, Walgreens, and Rite Aid use automated inventory systems that stock medications based on local demand. If your pharmacy doesn't see many Clomid prescriptions, it may not keep the drug on the shelf. This means your prescription might need to be special-ordered, adding 1-2 days to your wait.
Clomiphene Citrate has fewer generic manufacturers than many other medications. This concentrated market means that even minor disruptions — a production delay, a raw material shortage, a quality issue — can cause temporary gaps in availability.
More doctors are prescribing Clomid off-label for male hypogonadism (low testosterone) and male infertility. This growing demand from urologists and endocrinologists puts additional pressure on the supply of a medication historically used primarily in women's reproductive health.
Cost is another factor that affects access. Here's what you can expect to pay:
For a full breakdown of savings options, read our guide: How to Save Money on Clomid in 2026.
The fertility medication landscape continues to evolve:
Letrozole (Femara) has gained significant ground as a preferred alternative to Clomid, especially for PCOS patients. Many reproductive endocrinologists now prescribe Letrozole first due to studies showing comparable or better outcomes with fewer side effects. Generic Letrozole is widely available and costs only about $10 to $30 per cycle.
Enclomiphene — one of the two isomers that make up Clomiphene Citrate — is being studied as a potential standalone treatment for male hypogonadism. While not yet FDA-approved, enclomiphene may eventually offer a more targeted option for men using Clomid off-label, which could reduce demand pressure on the traditional Clomid supply.
Fertility-related telehealth has expanded significantly, making it easier for patients to get Clomid prescriptions without an in-person visit. Services like telehealth platforms can connect you with reproductive specialists and OB/GYNs who can prescribe Clomid. Learn more about finding a doctor who can prescribe Clomid.
If you need Clomid today, here's your action plan:
For more tips, read our complete guide: How to Find Clomid in Stock Near You.
The Clomid shortage of 2019-2023 is largely behind us, but finding the medication isn't always as simple as walking into your nearest pharmacy. By understanding the current landscape, using the right tools, and planning ahead, you can make sure a supply issue doesn't derail your fertility treatment.
Use Medfinder to find Clomid in stock near you, and talk to your doctor about your options — including whether alternatives like Letrozole might be right for your situation.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.